Perirenal fat and association with metabolic risk factors: The uberlândia heart study

Medicine (United States)

Volumn 94, Issue 38, 2015, Pages

  Roever, Leonardo ^a,d   Resende, Elmiro S ^a   Veloso, Fernando C ^a   Diniz, Angélica L D ^a   Penha Silva, Nilson ^a   Casella Filho, Antonio ^b   Dourado, Paulo M M ^b   Chagas, Antonio C P ^b,c  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FACULDADE DE MEDICINA DO ABC   (Brazil)

^d NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PERIRENAL FAT; PRIORITY JOURNAL; SEX DIFFERENCE; WAIST CIRCUMFERENCE; AGED; BODY MASS; BRAZIL; CARDIOVASCULAR DISEASES; ECHOGRAPHY; INTRAABDOMINAL FAT; KIDNEY; METABOLISM; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; BRAZIL; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; KIDNEY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84942518089     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001105     Document Type: Article

References (32)

1. Thom T, Haase N, Rosamond W, et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics: 2006 update-a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85e151.
2. Fox CS, Evans JC, Larson MG, et al. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation. 2004;110:522-527.
3. Hu FB, Stampfer MJ, Manson JE, et al. Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med. 2000;343:530-537.
4. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
5. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006;295: 1549-1555.
6. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377: 557-567.
7. Hall JE, da Silva AA, do Carmo JM, et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem. 2010;285:17271.
8. Dixon JB. The effect of obesity on health outcomes. Mol Cell Endocrinol. 2010;316:104-108.
9. Wang Y, Beydoun MA, Liang L, et al. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity. 2008;16:2323-2330.
10. Hayashi T, Boyko EJ, McNeely MJ, et al. Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans. Diabetes. 2008;57:1269.
11. Öhman MK, Shen Y, Obimba CI, et al. Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein e-deficient mice. Circulation. 2008;117:798-805.
12. Dolinkova M, Dostalova I, Lacinova Z, et al. The endocrine profile of subcutaneous and visceral adipose tissue of obese patients. Mol Cell Endocrinol. 2008;291:63-70.
13. Lamacchia O, Nicastro V, Camarchio D, et al. Para-and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients. Nephrol Dial Transplant. 2011;26:892.
14. Li Z, Woollard JR, Wang S, et al. Increased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferation. Am J Physiol Renal Physiol. 2011;301:F1078-F1087.
15. Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress. Circulation. 2007;116: 1234-1241.
16. Karunakaran I, Mohan AR, Jayagaopi S, et al. Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113) Clin Biochem. 2011;44:281-287.
17. Kawasaki S, Aoki K, Hasegawa O, et al. Sonographic evaluation of visceral fat by measuring para- and perirenal fat. J Clin Ultrasound. 2008;36:129-133.
18. Rea DJ, Heimbach JK, Grande JP, et al. Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int. 2006;70:1636-1641.
19. Li Z, Woollard JR, Wang S, et al. Increased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferation. Am J Physiol Renal Physiol. 2011;301:F1078-F1087.
20. Chughtai HL, Morgan TM, Rocco M, et al. Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension. 2010;56:901-906.
21. Kaplan NM. The Deadly Quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 1989;149:1514-1520.
22. Boyko EJ, Leonetti DL, Bergstrom RW, et al. Visceral adiposity, fasting plasma insulin, and blood pressure in Japanese-Americans. Diabetes Care. 1995;18:174.
23. Kanai H, Matsuzawa Y, Kotani K, et al. Close correlation of intraabdominal fat accumulation to hypertension in obese women. Hypertension. 1990;16:484-490.
24. Landsberg L. Hyperinsulinemia: possible role in obesity-induced hypertension. Hypertension. 1992;19:I-61-I-66.
25. DeFronzo RA. Insulin and renal sodium handling: clinical implications. Int J Obesity. 1981;5:93-104.
26. Sironi AM, Pingitore A, Ghione S, et al. Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat. Hypertension. 2008;51:282-288.
27. Filho RF, Faria A, Kohlmann O, et al. Ultrasonography for the evaluation of visceral fat and cardiovascular risk. Hypertension. 2001;38:713-717.
28. Mathieu P, Poirier P, Pibarot P, et al. Visceral obesity: the link among inflammation hypertension and cardiovascular disease. Hypertension. 2009;53:577-584.
29. Björntorp P. Portal adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis. 1990;10:493-494.
30. Bray GA, Gray DS. Treatment of obesity: an overview. Diabetes Metab. 1988;4:653-679.
31. Chughtai HL, Morgan TM, Michael Rocco M, et al. Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events. Hypertension. 2010;56:901-906.
32. Vries APJ, Piero P, Ruan ZX, et al. Fatty kidney: emerging role of ectopic lipid in obesity-related renal Disease. Lancet Diabetes Endocrinol. 2014;2:417-426.